What is innovationOchsner?
Ochsner Health System Named a National Innovation Finalist by Harvard Business and Medical Schools
Ochsner is one of four finalists in The Forum of Health Care Innovation’s Health Acceleration Challenge.
In the last few years, innovationOchsner has accomplished quite a bit – and its future looks very bright. Click through the timeline below to see some of iO's biggest milestones.
The Future
On the iO horizon: Stay tuned as we continue to more effectively manage chronic diseases through vision monitoring for failing eyesight and specialized inhalers for asthma and COPD.
Would you like to hear the latest on innovationOchsner?
Sign up for our email updates:
Our Collaborators
innovationOchsner is working with companies within the healthcare industry and outside of it to invest in — and invent — the future.
Tweets
RT @NYTHealth: Since 2007, Mylan has raised EpiPen prices from under $100 to over $600. The new generic version could drive down prices. ht…
RT @SecAzar: Today's announcement of the first FDA-approved generic version of EpiPen represents meaningful progress for American patients,…
Reducing hospital toxicity by avoiding circadian disruption: reduction in readmission
bit.ly/2LBnt6W… twitter.com/i/web/status/1…
They Thought Hemophilia Was a ‘Lifelong Thing.’ They May Be Wrong. nyti.ms/2P5fi5h
AI and Digital Medicine Provide Real-Time Data to Improve Patient Care ehealthcarestrategy.com/ai-and-digital… via @ehealtheditor